Skip to main content

Table 1 Association between SCD1 expression and clinicopathological characteristics of colorectal cancer patients

From: Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN

Clinical characteristics   SCD1 expression  
Number of case High (%) Low (%) P-value
Gender
 Male 16 12 (75) 4 (25) 1.00
 Female 6 4 (66.67) 2 (33.33)
Age(years)
  ≥ 60 18 13 (72.22) 5 (27.78) 1.000
  ≤ 60 4 3 (75) 1 (25)
Tumor size (cm2)
 <30 19 14 (73.68) 5(26.32) 1.000
  ≥ 30 3 2 (66.67) 1 (33.33)
Differentiation
 Well 5 2 (40) 3 (60) 0.100
 Moderate to poor 17 14 (82.35) 3 (17.65)
Tumor location
 Colon 13 10 (76.92) 3 (23.08) 0.655
 Rectum 9 6 (66.67) 3 (33.33)
Lymph metastasis
 Absent 10 5 (50) 5 (50) 0.056
 Present 12 11(91.67) 1 (8.33)
Distant metastasis
 Absent 20 14 (70) 6 (30) 1.000
 Present 2 2 (100) 0 (0)
TNM stage
 I + II 9 4 (44.44) 5 (55.56) 0.023*
 III + IV 13 12 (92.31) 1 (7.69)
  1. Samples with upregulated SCD1 expression showed a significant association with TNM stage (P = 0.023). One asterisk (*) indicated the statistical difference of P < 0.05